advertisement
Eye and vision (London, England) 16
Showing records 1 to 16 |
Display all abstracts in Eye and vision (London, England)104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationLambuk L
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaAng BCH
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationSuhaimi NAA
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaChiew W
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationSadikan MZ
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaYip VCH; Chua CH
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationJafri AJA
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaHan WS
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationAhmad S
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaTecson IOC
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationNasir NAA; Uskoković V
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaOgle JJ; Lim BA
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationKadir R
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaHee OK
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammationMohamud R; Mohamud R
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucomaTay ELY; Yong VKY; Wong HT; Yip LWL
Eye and vision (London, England) 2022; 9: 27